About imiglucera se
Enzyme replacement therapy
Used for
- Treating non-brain symptoms of type 1 or type 3 Gaucher disease
- Improving anemia, low platelets, enlarged liver or spleen, and bone problems
Usual adult dose
Usually 60 units/kg by intravenous infusion every two weeks; dose varies with disease severity and response.
Usual dose in children
Ages 2 years and older: usually 60 units/kg by intravenous infusion every two weeks; adjusted according to response.
Common side effects
- Headache, dizziness, or tiredness
- Nausea, vomiting, diarrhea, or abdominal pain
- Fever, chills, rash, or itching
- Infusion-site discomfort
Important warnings
- Severe allergic reactions, including anaphylaxis, can occur
- Infusion reactions may include breathing difficulty or chest discomfort
- Treatment requires supervised intravenous infusion
- Antibodies may develop and increase allergic reaction risk
Pregnancy
Available pregnancy data have not identified major risks; untreated Gaucher disease can also cause pregnancy complications.
Breastfeeding
Limited evidence suggests very low milk levels; effects on breastfed infants remain insufficiently studied.
Interactions
- No well-established clinically significant drug interactions
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.